Back with another version of scuttlebutt, some stuff I’ve seen or thought recently. I am particularly keen to get thoughts and opinions on alternative investments & the UK fin services sector. Buffett buys Teva Has Warren lost the plot? He’s bought a stake in Teva Pharmaceuticals which has an at EV/EBITDA of 12ish and something …
I have discovered what I believe to be literally the best business on Earth. Facebook? Google? Alibaba? Fraud manufacturing? Nup. It’s the Australian Securities and Investment Commission (ASIC) corporate database, ASIC Connect. This thing is a moneymaking machine. Let me put this to you. Zero customer acquisition and marketing costs – if you need a corporate report, …
The title of this piece comes from an interview with Getswift (ASX:GSW) executive chairman Bane Hunter. He’s spot on: Hunter has a clear message for all startup founders seeking US investment: “Data talks, bullshit walks,” he says. He advises founders to “be conservative and over deliver” when speaking to investors, because “everything you say is going to …
I’m revealing my undisclosed 10th purchase a little sooner than expected: It’s Tower Insurance Limited (ASX: TWR). I expect a 3-5 year holding period from here, subject to business performance. Conditions are also not quite as favourable as I had hoped for, so I have taken a smaller position with a view to increasing if a better …
One of the things I struggle with most with my ‘Buy’ pieces is the overlap between explaining what the opportunity is – which is easy – and explaining the thought process and research that lead to me believing that it is an opportunity – which is hard. Doing both at the same time usually leads …
I have sold all of my shares in Mayne Pharma (ASX:MYX), and despite the coincidental timing I swear it had nothing to do with Valeant. I would in general call this purchase a failure, although I was lucky to sell out without loss. Why sell? I recently had my Mayne Pharma thesis challenged, which was …
reprinted with permission from financialnews.net.com.network.au. Bringing you the hottest news in global finance FNNCNAU reporter Fiona Mastodon recently conducted a live interview with Yeti Bigfoot, founder of controversial activist investment fund 10Foot Capital. 10Foot Capital is in the midst of a major restructuring program as it attempts to rectify market-lagging performance. Here’s the interview transcript for …
There was a pearler of an announcement from the Getswift (ASX: GSW) this morning. I paraphrase: The share price didn’t move after we first announced the contract, therefore our Fruit Box contract was not material When Fruit Box was cancelled, we hadn’t completely finalised our contract with Commbank, but we were sure hoping to, because …
Not being a hotcopper member myself, I ask that people send me good stuff they see on there. I got this hilarious one overnight: I don’t assert that there is anything wrong with Fantastic Furniture or AFR here, but there is a certain humour in having to source a quote from a known fraud (Fantastic’s …
Can you still be a genius if your viewpoint is the same as everybody else in the market? Asking for a friend. You will know that I wrote about Getswift previously. In that post I focused a lot on the company’s deal with Amazon. I made the silly mistake of assuming that the company’s other contracts …